20
Participants
Start Date
March 31, 2007
Primary Completion Date
September 30, 2009
Study Completion Date
January 31, 2010
Placebo
single dose of Placebo injected s/c at 8am and monitor blood glucose over 24 hours
Insulin Glargine 0.5 u/kg body wt SC
8 weeks later, a differing dose (0.5, 1.0, 1.5, 2.0 u/kg body wt.) of Insulin Glargine and monitoring over a 24 hour period each separated by 8 weeks (5 separate study visits)
Insulin Glargine 1.0 u/kg body wt SC
Insulin Glargine 1.5 u/kg body wt SC
Insulin Glargine 2.0 u/kg body wt SC
Vanderbilt University, Nashville
Collaborators (1)
Sanofi
INDUSTRY
Vanderbilt University Medical Center
OTHER